New Research Sorting Out Risk Genes for Brain Disorders
By LabMedica International staff writers Posted on 09 Mar 2017 |

Image
Using targeted gene sequencing in a large cohort population, researchers have discovered genes associated with higher risk of neurodevelopmental-disorders (NDDs), with some of those genes showing statistical biases for autism. The study provides new information about similarities and differences underlying various NDDs.
To identify and better understand gene-disrupting mutations related to NDDs, a team led by researchers of the laboratory of Evan Eichler, University of Washington Health Sciences/UW Medicine and Howard Hughes Medical Institute, conducted a large, international, multi-institutional study. More than 11,700 affected individuals and nearly 2,800 control subjects underwent targeted DNA sequencing of 208 suspected disease-risk genes, candidate genes that were chosen based on previously published studies. Samples were collected through the Autism Spectrum/Intellectual Disability 15-center network spanning 7 countries and 4 continents. An advantage of this collection is the ability to check back on a large fraction of cases in attempt to relate genetic results to clinical findings.
In their study population, the researchers associated 91 genes with risk of a NDD, including 38 genes not previously suspected. Based on some of the family studies, however, mutations even in two or more of the risk genes may not be necessary or sufficient to cause disease.
Of the 91 genes, 25 were linked with forms of autism without intellectual disability. The scientists also described a gene network that appeared to be related to high-functioning autism. Individuals with this form of autism have average to above average intelligence, but may struggle in learning to talk, interact socially, or manage anxiety and sensory overload. Additional findings suggest that less severe mutations may be behind autism that is not accompanied by intellectual disability. Also notable, although the overall numbers were low, was that several autism risk genes appeared predominantly in males, including some detected exclusively in males who had autism without intellectual impairment.
While observing that some genes were more closely associated with autism and others with intellectual or developmental impairments, the researchers found that most of the genes implicated were mutated in both conditions. This result reinforces previous studies indicating substantial overlap among NDDs in their underlying genetics and observable characteristics.
"Most of these genes are clearly risk factors for neurodevelopmental disorders in a broad sense," the researchers said, "But analysis of both the genetic and subsequent patient follow-up data did single out some genes with a statistical bias towards autism spectrum disorder, rather than an intellectual disability or developmental delay." By combining clinical and genetic data, the researchers observed patterns enabling them to begin to assess how some of the genes might function and how their disruption might lead to specific traits or symptoms.
The researchers also used Drosophila to investigate 21 genes to determine if any of the mutations disrupted a specific form of learning: habituation – growing accustomed to harmless stimuli. Problems with the neuronal mechanisms behind habituation are thought to account for some autism features, such as inability to filter sensory input. The Drosophila studies showed habituation deficits from several of the gene mutations under review, thereby providing additional evidence that they may have a role in cognitive function.
"The scientists are continuing this project and are eager to work with interested families," said University of Washington Prof. Raphael Bernier, clinical director of the Seattle Children's Autism Center. Families can contact the project team at rablab@uw.edu.
The study, by Stessman HAF et al, was published online February 13, 2017, in the journal Nature Genetics.
To identify and better understand gene-disrupting mutations related to NDDs, a team led by researchers of the laboratory of Evan Eichler, University of Washington Health Sciences/UW Medicine and Howard Hughes Medical Institute, conducted a large, international, multi-institutional study. More than 11,700 affected individuals and nearly 2,800 control subjects underwent targeted DNA sequencing of 208 suspected disease-risk genes, candidate genes that were chosen based on previously published studies. Samples were collected through the Autism Spectrum/Intellectual Disability 15-center network spanning 7 countries and 4 continents. An advantage of this collection is the ability to check back on a large fraction of cases in attempt to relate genetic results to clinical findings.
In their study population, the researchers associated 91 genes with risk of a NDD, including 38 genes not previously suspected. Based on some of the family studies, however, mutations even in two or more of the risk genes may not be necessary or sufficient to cause disease.
Of the 91 genes, 25 were linked with forms of autism without intellectual disability. The scientists also described a gene network that appeared to be related to high-functioning autism. Individuals with this form of autism have average to above average intelligence, but may struggle in learning to talk, interact socially, or manage anxiety and sensory overload. Additional findings suggest that less severe mutations may be behind autism that is not accompanied by intellectual disability. Also notable, although the overall numbers were low, was that several autism risk genes appeared predominantly in males, including some detected exclusively in males who had autism without intellectual impairment.
While observing that some genes were more closely associated with autism and others with intellectual or developmental impairments, the researchers found that most of the genes implicated were mutated in both conditions. This result reinforces previous studies indicating substantial overlap among NDDs in their underlying genetics and observable characteristics.
"Most of these genes are clearly risk factors for neurodevelopmental disorders in a broad sense," the researchers said, "But analysis of both the genetic and subsequent patient follow-up data did single out some genes with a statistical bias towards autism spectrum disorder, rather than an intellectual disability or developmental delay." By combining clinical and genetic data, the researchers observed patterns enabling them to begin to assess how some of the genes might function and how their disruption might lead to specific traits or symptoms.
The researchers also used Drosophila to investigate 21 genes to determine if any of the mutations disrupted a specific form of learning: habituation – growing accustomed to harmless stimuli. Problems with the neuronal mechanisms behind habituation are thought to account for some autism features, such as inability to filter sensory input. The Drosophila studies showed habituation deficits from several of the gene mutations under review, thereby providing additional evidence that they may have a role in cognitive function.
"The scientists are continuing this project and are eager to work with interested families," said University of Washington Prof. Raphael Bernier, clinical director of the Seattle Children's Autism Center. Families can contact the project team at rablab@uw.edu.
The study, by Stessman HAF et al, was published online February 13, 2017, in the journal Nature Genetics.
Latest Molecular Diagnostics News
- Stool-Based DNA Testing Leads to Timely Colonoscopy
- Groundbreaking Tool Improves Genetic Testing Accuracy
- Biomarker Blood Test Could Predict Development of Long COVID
- Polygenic Risk Score Blood Test Predicts Future Breast Cancer
- AI-Powered Blood Tests Enable Early Detection of Alzheimer’s Disease
- Simple Urine Test Could Illuminate Hidden Tumors for Early Cancer Diagnosis
- Kidney Disease Blood Marker Could Also Identify Cardiovascular Problems
- Automated Molecular Tests Detect Bacterial Pathogens Causing Infectious Gastroenteritis
- New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer
- Novel Test Offers New Accuracy Level in Heart Attack Diagnosis
- Blood Test Detects Rheumatoid Arthritis in At-Risk Individuals Before Symptoms
- Simple Blood Test Identifies Metabolic Signature of Healthier Aging
- Rapid Blood Tests Differentiate Schizophrenia and Bipolar Disorder
- Low-Cost One-Hour HPV Test to Transform Cervical Cancer Screening
- Novel Leptospirosis Test Could Improve Treatment Options
- Simple Test Predicts Risk of Severe Liver Disease
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreHematology
view channel
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer
High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more
Luminescent Probe Measures Immune Cell Activity in Real Time
The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more
Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients
When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read moreMicrobiology
view channel
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read more
Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
Sepsis is a life-threatening condition that occurs when the body’s response to infection spirals out of control, damaging organs and leading to critical illness. Patients often arrive at intensive care... Read morePathology
view channel
High-Accuracy Tumor Detection Method Offers Real-Time Surgical Guidance
Pancreatic neuroendocrine neoplasms (PNENs) are rare cancers that affect hormone-producing cells in the pancreas. Although uncommon, their incidence has been increasing, and surgery remains the only curative option.... Read more
AI Tool Detects Hidden Warning Signs of Disease Inside Single Cells
Detecting early signs of disease at the cellular level remains a major challenge in medicine. Subtle molecular changes often precede visible symptoms, yet these early indicators are difficult to detect... Read moreTechnology
view channel
AI Algorithm Assesses Progressive Decline in Kidney Function
Chronic kidney disease (CKD) affects more than 700 million people worldwide and remains a major global health challenge. The condition often progresses silently, and many patients remain undiagnosed until... Read more
Taste-Based Influenza Test Could Replace Nasal Swabs with Chewing Gum
Influenza is one of the most dangerous infectious diseases worldwide, claiming around half a million lives each year. What makes it particularly insidious is that flu viruses are contagious even before... Read more
3D Micro-Printed Sensors to Advance On-Chip Biosensing for Early Disease Detection
Early-stage disease diagnosis depends on the ability to detect biomarkers with exceptional sensitivity and precision. However, traditional biosensing technologies struggle with achieving this at the micro-scale,... Read moreIndustry
view channel
Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
GSI Group Acquires Blood Processing Equipment Manufacturer GenesisBPS
Blood processing and storage are vital to healthcare and clinical practice, ensuring safe transfusions and cellular therapies. However, hospitals and laboratories worldwide face challenges in maintaining... Read more